Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SMLR

SMLR - Semler Scientific, Inc. Stock Price, Fair Value and News

$20.33 
Market Closed

74/100

SMLR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

74/100

SMLR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$29.97

Target 3M

$22.4

Target 6M

$24.68

SMLR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SMLR Price Action

Last 7 days

5.0%

Last 30 days

20.1%

Last 90 days

-12.3%

Trailing 12 Months

-65.1%

SMLR RSI Chart

SMLR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SMLR Valuation

Market Cap

308.2M

Price/Earnings (Trailing)

6.38

Price/Sales (Trailing)

8.34

EV/EBITDA

6.31

Price/Free Cashflow

-14.37

SMLR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$29.97

Target 3M

$22.4

Target 6M

$24.68

SMLR Fundamentals

SMLR Revenue

Revenue (TTM)

37.0M

Rev. Growth (Yr)

-44.56%

Rev. Growth (Qtr)

-8.84%

SMLR Earnings

Earnings (TTM)

48.3M

Earnings Growth (Yr)

201.34%

Earnings Growth (Qtr)

-74.75%

SMLR Profitability

Operating Margin

90.76%

EBT Margin

167.96%

Return on Equity

10.51%

Return on Assets

8.1%

Free Cashflow Yield

-6.96%

SMLR Investor Care

Shares Dilution (1Y)

108.63%

Diluted EPS (TTM)

3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202549.2M43.0M37.0M0
202465.9M61.7M58.9M56.3M
202360.9M64.7M66.9M68.2M
202253.9M54.4M54.4M56.7M
202142.4M50.3M53.6M53.0M
202035.4M33.9M35.7M38.6M
201923.8M26.3M29.6M32.8M
201814.9M17.8M19.7M21.5M
20178.0M8.9M10.6M12.5M
20167.3M7.6M8.1M7.4M
20154.0M4.5M5.1M7.0M
20142.7M3.1M3.4M3.6M
20130002.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Semler Scientific, Inc.

SMLR
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
 CEO
 WEBSITEsemlerscientific.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES127

Semler Scientific, Inc. Frequently Asked Questions

SMLR is the stock ticker symbol of Semler Scientific, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 21 2026, market cap of Semler Scientific, Inc. is 308.2 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check SMLR's fair value in chart for subscribers.

The fair value guage provides a quick view whether SMLR is over valued or under valued. Whether Semler Scientific, Inc. is cheap or expensive depends on the assumptions which impact Semler Scientific, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SMLR.

As of Wed Jan 21 2026, SMLR's PE ratio (Price to Earnings) is 6.38 and Price to Sales (PS) ratio is 8.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SMLR PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Semler Scientific, Inc. has provided 0.254 (multiply by 100 for percentage) rate of return.